REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,159,482 | +45.1% | 344,328 | +27.1% | 0.01% | +50.0% |
| Q2 2023 | $2,866,154 | +244.3% | 270,903 | +220.2% | 0.01% | +200.0% |
| Q1 2023 | $832,494 | -33.1% | 84,603 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $1,244,510 | +13.0% | 84,603 | -6.8% | 0.00% | 0.0% |
| Q3 2022 | $1,101,000 | -7.8% | 90,803 | +6.4% | 0.00% | 0.0% |
| Q2 2022 | $1,194,000 | -26.0% | 85,323 | -24.7% | 0.00% | 0.0% |
| Q1 2022 | $1,614,000 | -17.1% | 113,294 | +22.7% | 0.00% | -25.0% |
| Q4 2021 | $1,947,000 | +282.5% | 92,324 | +375.9% | 0.00% | +300.0% |
| Q3 2021 | $509,000 | -15.9% | 19,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $605,000 | +1.7% | 19,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $595,000 | -10.7% | 19,400 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $666,000 | +11.6% | 19,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $597,000 | +862.9% | 19,400 | +870.0% | 0.00% | – |
| Q2 2020 | $62,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |